The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

Abstract Background Coronavirus disease 2019 (COVID-19) has infected people in many countries worldwide. Discovering an effective treatment for this disease, particularly in severe cases, has become the subject of intense scientific investigation. Therefore, the objective of this study was to evalua...

Full description

Bibliographic Details
Main Authors: Naser Gharebaghi, Rahim Nejadrahim, Seyed Jalil Mousavi, Seyyed-Reza Sadat-Ebrahimi, Reza Hajizadeh
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Infectious Diseases
Subjects:
Coronavirus disease 2019
COVID-19
SARS-CoV-2
Severe infection
Intravenous immunoglobulin
Online Access:http://link.springer.com/article/10.1186/s12879-020-05507-4

Internet

http://link.springer.com/article/10.1186/s12879-020-05507-4

Similar Items